Sagimet Biosciences Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Kemble George | Executive Chairman | Sale | 37,688 | $7.69 | $289,821 | 81,005 | Nov 20, 2025 |
| Rozek Elizabeth | Chief Legal & Admin. Officer | Award / Grant | 9,855 | — | — | 193,581 | Nov 4, 2025 |
| Happel David | President & CEO | Sale | 65,478 | $9.13 | $597,814 | 689,722 | Jul 21, 2025 |
| Martins Eduardo Bruno | Chief Medical Officer | Sale | 8,277 | $9.13 | $75,569 | 106,936 | Jul 21, 2025 |
| Rozek Elizabeth | General Counsel and CCO | Sale | 10,780 | $9.13 | $98,421 | 183,726 | Jul 21, 2025 |
| Martins Eduardo Bruno | Chief Medical Officer | Award / Grant | 34,000 | — | — | 115,213 | Feb 6, 2025 |
| Happel David | President & CEO | Award / Grant | 116,000 | — | — | 755,200 | Feb 6, 2025 |
| Rozek Elizabeth | General Counsel and CCO | Award / Grant | 34,000 | — | — | 194,506 | Feb 6, 2025 |
| Chauche Thierry | Chief Financial Officer | Award / Grant | 17,000 | — | — | 17,000 | Feb 6, 2025 |
| Kemble George | Executive Chairman | Sale | 23,625 | $3.17 | $74,891 | 118,693 | Jul 23, 2024 |
| Martins Eduardo Bruno | Chief Medical Officer | Sale | 8,357 | $3.10 | $25,907 | 81,213 | Jul 19, 2024 |
| Rozek Elizabeth | General Counsel and CCO | Sale | 10,914 | $3.10 | $33,833 | 160,506 | Jul 19, 2024 |
| Kemble George | Executive Chairman | Sale | 14,062 | $3.10 | $43,592 | 142,318 | Jul 19, 2024 |
| Happel David | President & CEO | Purchase | 12,100 | $5.27 | $63,767 | 639,200 | Mar 26, 2024 |
| SANDELL SCOTT D | — | Other | 260,950 | — | — | — | Jan 29, 2024 |
| KERINS PATRICK J | — | Other | 260,950 | — | — | — | Jan 29, 2024 |
| BASKETT FOREST | — | Other | 850,000 | — | — | 3,000,275 | Jan 29, 2024 |
| NEA 13 GP, Ltd | — | Other | 260,950 | — | — | — | Jan 29, 2024 |
| NEW ENTERPRISE ASSOCIATES 13 LP | — | Other | 850,000 | — | — | 3,000,275 | Jan 29, 2024 |
| Happel David | President & CEO | Purchase | 1,600 | $4.10 | $6,560 | 627,100 | Dec 7, 2023 |
| Rozek Elizabeth | General Counsel and CCO | Award / Grant | 171,420 | — | — | 171,420 | Nov 17, 2023 |
| Martins Eduardo Bruno | Chief Medical Officer | Award / Grant | 89,570 | — | — | 89,570 | Nov 17, 2023 |
| Kemble George | Executive Chairman | Award / Grant | 150,750 | — | — | 156,380 | Nov 17, 2023 |
| Happel David | President & CEO | Award / Grant | 624,910 | — | — | 625,500 | Nov 17, 2023 |
| Happel David | President & CEO | Purchase | 590 | $2.35 | $1,387 | 590 | Nov 16, 2023 |
| Kemble George | Executive Chairman | Option Exercise | 5,630 | $0.79 | $4,448 | 5,630 | Sep 7, 2023 |
| KERINS PATRICK J | — | Other | 37,676 | — | — | — | Jul 18, 2023 |
| KPCB PANDEMIC & BIO DEFENSE FUND LLC | — | Other | 38,763 | — | — | — | Jul 18, 2023 |
| SEIDENBERG BETH C | — | Purchase | 46,875 | $16.00 | $750,000 | 46,875 | Jul 18, 2023 |
| Wu Jinzi Jason | — | C | 1,654,701 | — | — | 1,654,701 | Jul 18, 2023 |
| Parsey Merdad | — | Disposition | 8,677 | — | — | — | Jul 18, 2023 |